Just to address an old dead horse that one of R favorite
Just to address an old dead horse that one of R favorite posters is dredging up at the swamp:
Menon settled the patent dispute with his EMPLOYEE so that the company would not be embroiled in litigation. Menon must not have understood the U.S. patent system, because he failed to get Aruda to sign a contract stating that Aruda was doing "work for hire" -- which he was -- and instead, because Menon did not have such a contract, Aruda (who carried out tasks for Menon) sued to be considered a "co-discoverer."
I have some experience with this issue and it would never occur to a regular person that someone you hire to do work can claim to own part of the intellectual property, if you fail to get them to sign an agreement explicitly stating that they are doing work for hire and don't have intellectual property rights, and if that person takes advantage of that lack of a written contract to sue.
Obviously I don't have access to all the documents and all the facts, but I think that it is likely that Dr. Menon would have prevailed in court, had he chosen to fight Aruda's claim. Instead, for the good of the company, he settled with him so that the company could continue developing Kevetrin without the specter of litigation hanging over it. It is very common for people or companies to decide to settle rather than being involved in expensive and protracted litigation.
This is what the term "greenmail" means. It's the essence of the business plan for ambulance-chasing "shareholder suit" law firms like the Rosen Firm.
It was an expensive mistake for Dr. Menon, but it is ancient history now.
By the way, if you ever hire a photographer, make sure that you get them to sign a statement that YOU own the copyright. Otherwise, you can pay someone a ton of money for photographs, and you will discover that YOU do not have the right to make copies -- only the copyright owner does.
2
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Understanding Oscar Health's Recent Options Activity In the fast-paced world of trading, Oscar Health Inc’s (NYSE: OSCR) recent options activity has captured significant attention among savvy investors. Notably, there has been a notable bullish sentiment from wealthy investors towards this health insurance company. Tracking public options data reveals movements that...
Continue Reading
Better Choice Company Settles on Halo Asia Sale Better Choice Company, Inc. (BTTR), a leader in pet health and wellness, has recently reached a significant milestone by signing a definitive agreement to sell its Halo business in Asia. This sale is projected to generate total gross proceeds of $8.1 million, which encompasses $6.5 million in cash at the closing of the deal....
Continue Reading
Fastenal Prepares for Earnings Report Fastenal (NASDAQ: FAST) is gearing up to release its quarterly earnings report. Investors are keenly anticipating the upcoming announcement, as it offers a glimpse into the company's financial performance. This article provides essential insights and analysis for those eager to understand what to expect from Fastenal's announcement....
Continue Reading
Compass Therapeutics Advances Cancer Research BOSTON — Compass Therapeutics, Inc. (Nasdaq: CMPX), a promising player in the biotechnology sphere focused on developing innovative therapies for cancer, has made significant strides in its clinical research. The company has announced that the first patient has been dosed in a groundbreaking Investigator Sponsored Trial...
Continue Reading
Overview of the ECB Fine Imposed on LHV Group The European Central Bank (ECB) has recently informed AS LHV Group about a decision to levy an administrative fine amounting to EUR 405 thousand. This fine is linked to an error identified in the consolidated regulatory reporting for a specified timeframe. The issue arose from discrepancies in how the equity of LHV Bank...
Continue Reading